Cargando…

Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer

Liver cancer is the third most common cause of cancer-related death following lung and stomach cancers. As a highly lethal disease, liver cancer is diagnosed frequently in less developed countries. Natural compounds extracted from herbs, animals and natural materials have been adopted by traditional...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yannan, Zhang, Wenhui, Xu, Lin, Zhou, Hua, Yuan, Man, Xu, Hongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825370/
https://www.ncbi.nlm.nih.gov/pubmed/35155196
http://dx.doi.org/10.3389/fonc.2021.795548
_version_ 1784647193853952000
author Zheng, Yannan
Zhang, Wenhui
Xu, Lin
Zhou, Hua
Yuan, Man
Xu, Hongxi
author_facet Zheng, Yannan
Zhang, Wenhui
Xu, Lin
Zhou, Hua
Yuan, Man
Xu, Hongxi
author_sort Zheng, Yannan
collection PubMed
description Liver cancer is the third most common cause of cancer-related death following lung and stomach cancers. As a highly lethal disease, liver cancer is diagnosed frequently in less developed countries. Natural compounds extracted from herbs, animals and natural materials have been adopted by traditional Chinese medicine (TCM) practices and reported to be effective in the development of new medications for the treatment of diseases. It is important to focus on the mechanisms of action of natural compounds against hepatocellular carcinoma (HCC), particularly in terms of cell cycle regulation, apoptosis induction, autophagy mediation and cell migration and invasion. In this review, we characterize novel representative natural compounds according to their pharmacologic effects based on recently published studies. The aim of this review is to summarize and explore novel therapeutic drug targets of natural compounds, which could accelerate the discovery of new anticancer drugs.
format Online
Article
Text
id pubmed-8825370
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88253702022-02-10 Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer Zheng, Yannan Zhang, Wenhui Xu, Lin Zhou, Hua Yuan, Man Xu, Hongxi Front Oncol Oncology Liver cancer is the third most common cause of cancer-related death following lung and stomach cancers. As a highly lethal disease, liver cancer is diagnosed frequently in less developed countries. Natural compounds extracted from herbs, animals and natural materials have been adopted by traditional Chinese medicine (TCM) practices and reported to be effective in the development of new medications for the treatment of diseases. It is important to focus on the mechanisms of action of natural compounds against hepatocellular carcinoma (HCC), particularly in terms of cell cycle regulation, apoptosis induction, autophagy mediation and cell migration and invasion. In this review, we characterize novel representative natural compounds according to their pharmacologic effects based on recently published studies. The aim of this review is to summarize and explore novel therapeutic drug targets of natural compounds, which could accelerate the discovery of new anticancer drugs. Frontiers Media S.A. 2022-01-26 /pmc/articles/PMC8825370/ /pubmed/35155196 http://dx.doi.org/10.3389/fonc.2021.795548 Text en Copyright © 2022 Zheng, Zhang, Xu, Zhou, Yuan and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zheng, Yannan
Zhang, Wenhui
Xu, Lin
Zhou, Hua
Yuan, Man
Xu, Hongxi
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title_full Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title_fullStr Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title_full_unstemmed Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title_short Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
title_sort recent progress in understanding the action of natural compounds at novel therapeutic drug targets for the treatment of liver cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825370/
https://www.ncbi.nlm.nih.gov/pubmed/35155196
http://dx.doi.org/10.3389/fonc.2021.795548
work_keys_str_mv AT zhengyannan recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer
AT zhangwenhui recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer
AT xulin recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer
AT zhouhua recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer
AT yuanman recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer
AT xuhongxi recentprogressinunderstandingtheactionofnaturalcompoundsatnoveltherapeuticdrugtargetsforthetreatmentoflivercancer